Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Abbvie Inc shares valued at $13,231,264 were purchased by Richard A. Gonzalez on Aug 22 ’25. At $210.84 per share, Richard A. Gonzalez acquired 62,755 shares.
Also, Richard A. Gonzalez purchased 90,000 shares, netting a total of over 18,993,948 in proceeds.
Before that, SALEKI-GERHARDT AZITA had sold 42,370 shares from its account. In a trade valued at $8,407,055, the EVP, CHIEF OPERATIONS OFFICER traded Abbvie Inc shares for $198.42 each. Upon closing the transaction, the insider’s holdings decreased to 42,370 shares, worth approximately $39.92 million.
As published in a research note from HSBC Securities on December 10, 2025, Abbvie Inc [ABBV] has been rated up from a Hold to a Buy and the price target has been revised to $265. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in mid November. As of November 04, 2025, DZ Bank has decreased its “Buy” rating to a “Hold” for ABBV. Earlier on October 14, 2025, Erste Group downgraded its rating. Their new recommendation was “a Hold” for ABBV stock which previously was a “a Buy”.
Analyzing ABBV Stock Performance
On last trading session, Abbvie Inc [NYSE: ABBV] rose 0.98% to $225.18. The stock’s lowest price that day was $221.0, but it reached a high of $225.98 in the same session. During the last five days, there has been a drop of approximately -2.20%. Over the course of the year, Abbvie Inc shares have jumped approximately 27.81%. Shares of the company reached a 52-week high of $244.81 on 10/01/25 and a 52-week low of $164.39 on 04/09/25.
Support And Resistance Levels for Abbvie Inc (ABBV)
According to the 24-hour chart, there is a support level at 222.13, which, if violated, would cause prices to drop to 219.07. In the upper region, resistance lies at 227.11. The next price resistance is at 229.03. RSI (Relative Strength Index) is 47.46 on the 14-day chart, showing neutral technical sentiment.
Is Abbvie Inc subject to short interest?
Stocks of Abbvie Inc saw a sharp steep in short interest on 2025-11-28 dropping by -0.68 million shares to 18.21 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 18.89 million shares. A decline of -3.75% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.89 of the overall float, the days-to-cover ratio (short ratio) decline to 2.89.
Which companies own the most shares of Abbvie Inc (ABBV)?
In terms of Abbvie Inc share price expectations, FactSet research, analysts set an average price target of 253.5 in the next 12 months, up nearly 13.68% from the previous closing price of $222.99. Analysts anticipate Abbvie Inc stock to reach 289 by 2025, with the lowest price target being 242. In spite of this, 27 analysts ranked Abbvie Inc stock as Buy at the end of 2025.
